A new study indicates that some women may explain that some women end up with heart attacks and strikes although they are in good health, as a new study indicates.
The researchers reported that the analysis of 30 years of data from more than 12,000 women revealed that inflammation was similar to the high cholesterol LDL as a risk factor in heart disease. The results were published simultaneously in European Heart Magazine.
Inflammation is not a standard part of the examination in the United States and there are no external signs that a person may have high levels.
The main author of the study at the Harvard University College of Medicine said that inflammation can cause the risk of a heart attack or stroke even when other risk factors – such as high cholesterol, smoking high and high blood pressure – in the study, and professor at Harvard University Medical College.
“Half of all heart attacks and strokes occur in people who have no major risk factors,” Ruker said.
Dr. Anis Hosfatir, cardiologist and co-manager of the Cardio-OBStetrics Research Program in NYU Langone Health, called for the study “Possible to change.”
“Although there is an increasing group of evidence that inflammation is an incredibly important cardiovascular risk factor and recommends that most of them should be examined, the vast majority of women are not examined,” said Hausvater, who was not involved in the research.
The incomplete blood test of what is known as high -sensitive CRP can measure the inflammatory. Ridker said that in Europe it is already the standard of care for HSCRP measurement.
The new study used data from the study of women’s health, which was launched by the National Institute of Heart of the Lung and Blood in the early 1990s.
Initially, blood samples were collected from women to measure cholesterol and HSCRP levels.
Of nearly 28,000 women who provided a basic blood test, 12,530 have no standard risk factors for heart disease, or “SMURFS”. During the 30 years of follow-up, there were 973 cardiovascular event-such as a heart attack or stroke-in this group. HSCRP levels were much higher among women who tried them.
Ridker said that the new results indicate that inflammation should be included in heart disease shows. High inflammation can be treated with statistics, but with a healthy cholesterol reading, these women will not qualify for a prescription.
former Clinical I found that women who do not have modified normative risk factors can benefit from treatment with statin. Ridker said that this experiment showed that women with high inflammation, but there are no other risk factors that have witnessed a 38 % decrease in serious cardiovascular events such as stroke and heart attack if they receive statin treatment.
But if HSCRP is not measured, these women will not get a life -saving treatment that needs them, Ridker said. “The bottom line is that doctors will not deal with what they do not measure,” he said.
Hausvater said that the examination should be a routine for all women.
She said, “This is another tool that should be provided to evaluate their risks,” she said. “I would like to say, based on this study, I recommend that patients ask their doctors to check HSCRP.”
Dr. Tania Ruiz, cardiologist and professor of medicine at the Medical Center at Vanderbilt University. “This is a very exciting study,” she said. “It is the first large -scale HSCRP study as a prediction of cardiovascular events in healthy women.”
“In recent years, we have learned more about the role of inflammation in forming paintings and weakness in the plaque,” Ruiz said.
Ruiz said that women with autoimmune diseases such as lupus may have a high degree of HSCRP. Otherwise, without testing, there is no way to know.